Top Industry Leaders in the Transverse Myelitis Market
Latest Transverse Myelitis Companies Updates:
Annexon Biosciences (NASDAQ: ANEX): Announced positive Phase 2b data for their cannabinoid CB2 receptor agonist, CB2A-129, in treating acute optic neuritis, a condition often associated with transverse myelitis.
Viela Bio (Viela Bio): Initiated a Phase 2 clinical trial evaluating their anti-IL-17A antibody, inebilizumab, for treating neuromyelitis optica spectrum disorder (NMOSD), a condition sometimes overlapping with transverse myelitis.
Rare Disease Foundation: Launched a new initiative to raise awareness and support research for transverse myelitis and other rare neurological disorders.
List of Transverse Myelitis companies in the market:
- Medtronic, Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Baxter International, Inc.
- Amgen Inc.
- Johnson & Johnson Consumer Inc.
- Bayer AG
- Pfizer, Inc.
- Cerus Corporation